ask="N/A"
ask_size="N/A"
average_daily_volume="31514"
bid="3.120"
bid_size="100"
book_value="3.340"
change="-0.255"
change_from_200_day_moving_average="1.584"
change_from_50_day_moving_average="1.933"
change_from_52_week_high="-1.612"
change_From_52_week_low="4.655"
change_in_percent="-3.025%"
close="8.175"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-2.262"
ebitda="-50.28M"
eps_estimate_current_year="-2.600"
eps_estimate_next_quarter="-0.630"
eps_estimate_next_year="-2.850"
ex_dividend_date="N/A"
float_shares="686000"
high="8.676"
high_52_weeks="9.787"
last_trade_date="1/30/2017"
last_trade_price="8.175"
last_trade_size="100"
last_trade_time="3:59pm"
low="7.980"
low_52_weeks="3.520"
market_capitalization="173.96M"
moving_average_200_day="6.591"
moving_average_50_day="6.242"
name="Nabriva Therapeutics AG"
notes="N/A"
one_year_target_price="16.240"
open="8.490"
pe_ratio="N/A"
peg_ratio="0.000"
percent_change_from_200_day_moving_average="+24.028%"
percent_change_from_50_day_moving_average="+30.961%"
percent_change_from_52_week_high="-16.472%"
percent_change_from_52_week_low="+132.244%"
previous_close="8.430"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="2.524"
price_per_sales="34.497"
revenue="5.20M"
shares_outstanding="21280000"
short_ratio="4.800"
stock_exchange="NMS"
symbol="NBRV"
volume="27034"
weeks_range_52="3.520 - 9.787"
